Hans C. Lee, MD

• Multiple Myeloma
• Waldenström's Macroglobulinemia
• AL amyloidosis

Dr. Hans Lee currently serves as the Director of Multiple Myeloma Research at the Sarah Cannon Research Institute (SCRI). Prior to his move to SCRI, he was an Associate Professor and Director of Multiple Myeloma Clinical Research in the Department of Lymphoma/Myeloma at MD Anderson Cancer Center. He received his MD from Indiana University. Subsequently, he completed his internal medicine residency training at Washington University in St. Louis, followed by a hematology/oncology fellowship at MD Anderson Cancer Center. Dr. Lee's clinical and research efforts are focused on advancing the care and treatment of patients with multiple myeloma and other plasma cell dyscrasias. In addition to his leadership role at SCRI, Dr. Lee serves as a medical oncologist at SCRI Oncology Partners in Nashville, Tennessee.